Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

[1]  K. Siminovitch,et al.  Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  A. Schambach,et al.  Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  Christof von Kalle,et al.  The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. , 2009, The Journal of clinical investigation.

[4]  T. Hawley,et al.  Combinatorial Incorporation of Enhancer‐Blocking Components of the Chicken β‐Globin 5′HS4 and Human T‐Cell Receptor α/δ BEAD‐1 Insulators in Self‐Inactivating Retroviral Vectors Reduces Their Genotoxic Potential , 2008, Stem cells.

[5]  I. Robinson,et al.  Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors , 2008, Journal of Virology.

[6]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[7]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[8]  A. Schambach,et al.  Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16 , 2008, Leukemia.

[9]  F. Bushman,et al.  DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer , 2008, Nucleic acids research.

[10]  A. Schambach,et al.  Physiological promoters reduce the genotoxic risk of integrating gene vectors. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  J. Gray,et al.  Globin Lentiviral Vector Insertions Can Perturb the Expression of Endogenous Genes in β-thalassemic Hematopoietic Cells. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Alessandro Aiuti,et al.  Hot spots of retroviral integration in human CD34+ hematopoietic cells. , 2007, Blood.

[13]  X. Agirre,et al.  Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  A. Schambach,et al.  Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  O. Danos,et al.  Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients , 2007, Gene Therapy.

[16]  C. Shaw,et al.  Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways. , 2007, Blood.

[17]  A. Schambach,et al.  Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors , 2006, Gene Therapy.

[18]  Christof von Kalle,et al.  and insertional genotoxicity Cell culture assays reveal the importance of retroviral vector design for , 2006 .

[19]  Paul Shinn,et al.  Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection , 2006, PLoS pathogens.

[20]  C. von Kalle,et al.  Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque. , 2006, Blood.

[21]  David A. Williams,et al.  Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. , 2006, Experimental hematology.

[22]  Yang Du,et al.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.

[23]  G. Nucifora,et al.  EVI1 and hematopoietic disorders: history and perspectives. , 2006, Gene.

[24]  David A. Williams,et al.  Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  N. Copeland,et al.  Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. , 2005, Blood.

[26]  A. Berns,et al.  Retroviral insertional mutagenesis: past, present and future , 2005, Oncogene.

[27]  B. Fehse,et al.  Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking , 2005, Science.

[28]  J. Dick,et al.  Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. , 2004, Blood.

[29]  B. Fehse,et al.  Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. , 2003, Experimental hematology.

[30]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[31]  David A. Williams,et al.  Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. , 2003, Human gene therapy.

[32]  P. Zipfel,et al.  In Vivo Analysis of Retroviral Enhancer Mutations in Hematopoietic Cells: SP1/EGR1 and ETS/GATA Motifs Contribute to Long Terminal Repeat Specificity , 2002, Journal of Virology.

[33]  A. Furger,et al.  The Retroviruses Human Immunodeficiency Virus Type 1 and Moloney Murine Leukemia Virus Adopt Radically Different Strategies To Regulate Promoter-Proximal Polyadenylation , 2001, Journal of Virology.

[34]  T. Hope,et al.  Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors , 1999, Journal of Virology.

[35]  F. Gage,et al.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Luigi Naldini,et al.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics , 2001, Nature Medicine.